• 5 rue du Gabian, 98 000 Monaco info@serelyspharma.com


4 millions of men are concerned

  • 1 in 3 men in France suffer from erectile disorders after the age of 40 years1
  • 13% of men over the age of 40 say they have a loss of sexual desire (libido)2


Consequently, more than 4 million men are affected by libido or erectile disorders.


The reasons for this inconvenience are many and multifactorial. 80% of problems are psychogenic, 10% are purely organic in nature and 10% are of mixed origin.

Erectile disorders can be related to a low testosterone level.

Testosterone deficiency syndrome affects 6-9% of men aged 40 to 70 years3,4  and rises to 15-30% in diabetic or obese subjects.

The reduction in testosterone is unavoidable and related to age.

Other factors can also be the root cause of erectile disorders, such as metabolic syndrome linked to obesity, high blood pressure, cholesterol and diabetes.


In the case of erectile dysfunction, men are first advised to modify their lifestyle and adopt a better diet and/or exercise more.


PDE5 inhibitors (such as Viagra, Cialis, Spedra) also make up part of the solution that are suggested.

These ‘drugs’ have a mechanical action (30 minutes until 2 hours after taken). They require medical monitoring and in some cases are poorly tolerated.

Furthermore, 30% of patients who take PDE5 inhibitors do not respond to these treatment.



Manolis® is a unique and patented synergy of 3 natural active ingredients : Tribulus terrestris, Ecklonia bicyclis and chitosan.

This unique complex called Tradamixina® has been proven to be safe and effective in various clinical studies. 5-6-7

Due to the presence in particular of the Tribulus terrestris within the formula, the red Manolis® pill contributes to the maintenance of good sexual function in men

  1. Giuliano et al Progrès en urologie 2002
  2. Buvat et coll, International Journal of Urology (2009)
  3. Araujo AB, O’Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al Clin Endocrinol Metab 2004.
  4.  Arnott J. 88th Annual Meeting of the Endocrine Society. Boston, MA, 2006.
  5. Iacono F et al BMC Surgery Mai 2012.
  6. Sansalone S et al. Biomed Res Int 2014
  7. Russo A et al Health 2016